Physician profile
Christopher John Eberle
NPI 1689200552
$5,973.61
in general payments reported to CMS, 2019-2025
15 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,868 · 2024: $307 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,175 · Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,174.84 |
| Food and Beverage | $1,798.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,237.54 | 2023-2025 | Prostep, Prophecy, Infinity |
| Mimedx Group, INC. | $269.34 | 2024-2025 | Epi Line Products All Epi |
| Reapplix INC. | $126.66 | 2025 | 3c Patch Kit - Box |
| Kerecis Limited | $118.95 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $30.21 | 2025 | Apligraf |
| Abbvie INC. | $26.57 | 2024 | |
| Nevro Corp. | $26.43 | 2024 | Senza |
| Integra Lifesciences Corporation | $23.99 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $21.75 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.53 | 2024 | Jardiance |
| Novo Nordisk INC | $18.52 | 2025 | Ozempic, Rybelsus |
| Kci USA, INC. | $17.00 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Dexcom, INC. | $16.16 | 2024 | Dexcom G6 Transmitter |
| Tactile Systems Technology INC | $14.38 | 2025 | Nimbl, Flexitouch Plus |
| Orthofix Medical, INC. | $6.58 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Eberle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.